vTv Therapeutics (VTVT) Free Cash Flow (2016 - 2025)
Historic Free Cash Flow for vTv Therapeutics (VTVT) over the last 12 years, with Q3 2025 value amounting to -$5.2 million.
- vTv Therapeutics' Free Cash Flow rose 1863.51% to -$5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$20.8 million, marking a year-over-year increase of 1097.2%. This contributed to the annual value of -$25.3 million for FY2024, which is 3262.93% down from last year.
- Latest data reveals that vTv Therapeutics reported Free Cash Flow of -$5.2 million as of Q3 2025, which was up 1863.51% from -$5.1 million recorded in Q2 2025.
- In the past 5 years, vTv Therapeutics' Free Cash Flow ranged from a high of $706000.0 in Q2 2022 and a low of -$8.8 million during Q3 2022
- Moreover, its 5-year median value for Free Cash Flow was -$5.2 million (2025), whereas its average is -$5.0 million.
- As far as peak fluctuations go, vTv Therapeutics' Free Cash Flow soared by 11765.88% in 2022, and later plummeted by 97351.27% in 2023.
- Quarter analysis of 5 years shows vTv Therapeutics' Free Cash Flow stood at -$6.4 million in 2021, then dropped by 7.22% to -$6.9 million in 2022, then surged by 57.65% to -$2.9 million in 2023, then tumbled by 65.58% to -$4.8 million in 2024, then decreased by 8.23% to -$5.2 million in 2025.
- Its Free Cash Flow was -$5.2 million in Q3 2025, compared to -$5.1 million in Q2 2025 and -$5.7 million in Q1 2025.